NASDAQ
ILMN
Last Price
US $191.20
KEY FIGURES
MKT CAP
$28.9B
EPS
TTM
$5.58
PEG
TTM
0.26x
P/E
TTM
34.29x
P/S
TTM
6.66x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Illumina, Inc. cash flow to debt ratio of 42.26% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial stability - Healthy cash flow growth.
Illumina, Inc.'s free cash flow has increased 31.31% from $709.00M last year to $931.00M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Illumina, Inc.'s debt to equity ratio is 0.95, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
Illumina, Inc.'s debt has decreased relative to shareholder equity from 1.10 last year to 0.95 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Illumina, Inc. has a net debt to EBITDA ratio of 0.78x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Illumina, Inc.'s interest coverage ratio of 12.39 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Illumina, Inc.'s profit margin has increased (-169.44%) in the last year from -27.97% to 19.43%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Illumina, Inc.'s short-term assets of $3.29G exceed its short-term liabilities of $1.58G
Increasing performance - ROA.
Illumina, Inc.'s return on assets of 13.01% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Illumina, Inc.'s return on equity of 33.99%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Illumina, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Decreasing performance - Earnings stability.
Illumina, Inc. had positive net income in only 2.00 out of 5 years, indicating unstable earnings
Increasing performance - Free cash flow.
Illumina, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Illumina, Inc. has a free cash flow yield of 3.22%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Illumina, Inc.'s yearly earnings has increased -169.50% since last year from $-1.22G to $850.00M, signaling increasing performance
Decreasing performance - Healthy revenue growth.
Illumina, Inc.'s yearly revenue has decreased -0.69% since last year from $4.37G to $4.34G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 13.59% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
Illumina, Inc.'s 3-year revenue CAGR of -1.82% is negative, indicating declining revenue over the past 3 years
Decreasing performance - Revenue consistency.
Illumina, Inc. had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance
Decreasing performance - ROE consistency.
Illumina, Inc. had positive ROE in only 2.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Illumina, Inc. is overvalued relative to its fair value price of 66.61 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Illumina, Inc. has an earnings yield of 2.92%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Illumina, Inc. is overvalued relative to its fair value price of 59.29 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Illumina, Inc. has an EV/EBITDA ratio of 20.63x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Undervalued - PEG ratio value.
Illumina, Inc. has a PEG-ratio under 1 which is considered undervalued
Overvalued - P/B ratio.
Illumina, Inc. has a price-to-book ratio of 10.93x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Undervalued - P/S ratio.
Illumina, Inc. has a price-to-sales ratio of 6.66x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
33.99%
Return on equity
ROIC: 13.59%
Valuation History
34.3X
Price to Earnings
EV/EBITDA: 21.5X
Cash flow
Profit margin
7.58%
(FY vs FY)
EBITDA Y/Y
7.48%
(FY vs FY)
Cash flow Y/Y
0.88%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $191.20
-65.16%
Default assumptions
EBITDA Multiple
Fair Value
Market $191.20
-68.99%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.